ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

COYA Coya Therapeutics Inc

8.68
-0.10 (-1.14%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Coya Therapeutics Inc COYA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.10 -1.14% 8.68 06:30:00
Open Price Low Price High Price Close Price Previous Close
8.95 8.67 9.06 8.68 8.78
more quote information »

Recent News

Date Time Source Heading
26/4/202422:15BWCoya Therapeutics Presents Updated ALS Biomarker Data at the..
22/4/202422:15BWCoya Therapeutics to Participate in the Mizuho Neuroscience..
18/4/202422:15BWCoya Therapeutics to Participate in the 3rd Annual ALS Drug..
08/4/202422:15BWCoya Therapeutics Scientific Advisory Board Chairman Dr...
19/3/202423:15BWCoya Therapeutics Provides a Corporate Update and Reports..
13/3/202400:00BWCoya Therapeutics to Participate in BTIG Fireside Discussion
12/3/202423:00BWCoya Therapeutics Presents ALS Biomarker Data at Society of..
07/3/202400:15BWCoya Therapeutics Presents Biomarker Data on..
06/3/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:15BWCoya Therapeutics to Present Data on Immune System and..
23/2/202400:15BWCoya Therapeutics to Present Novel Biomarker Survival Data..
22/2/202400:15BWCoya Therapeutics Issues Letter to Stockholders Highlighting..
14/2/202400:15BWCoya Therapeutics Licenses Intellectual Property Rights for..
03/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202400:15BWCoya Therapeutics SAB Chairman Dr. Stanley Appel, M.D...
20/1/202410:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202410:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202410:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202400:15EDGAR2Form 8-K - Current report
19/1/202400:15BWCoya Therapeutics to Participate in Upcoming Chardan Biotech..
17/1/202408:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/1/202400:15BWCoya Therapeutics Announces Pipeline Expansion of COYA 302..
16/1/202420:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
16/1/202419:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
06/1/202400:00BWCoya Therapeutics Announces Successful Pre-IND and Type C..
05/1/202408:46EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202301:46EDGAR2Form D - Notice of Exempt Offering of Securities
21/12/202300:35EDGAR2Form 8-K - Current report
21/12/202300:30BWMr. Wilbur L. Ross, Former United States Secretary of..
14/12/202300:00BWCoya Therapeutics’ CEO Dr. Howard Berman’s Letter to..
13/12/202300:00BWCoya Therapeutics Announces Closing of $26.5 Million Private..
06/12/202323:30EDGAR2Form 8-K - Current report
06/12/202323:05BWCoya Therapeutics Announces $26.5 Million Private Placement
06/12/202323:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
09/11/202301:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202301:03EDGAR2Form 8-K - Current report
09/11/202301:00BWCoya Therapeutics, Inc. Provides Business Update and Reports..
28/10/202300:00BWCoya Announces Acceptance of Oral Presentation, “Regulatory..
09/10/202323:00BWCoya Therapeutics (Coya) Announces Completion of Enrollment..
06/10/202300:00BWCoya Therapeutics Presents New Experimental Data Supporting..
04/10/202300:00BWCoya Therapeutics Announces the Presentation of Human..
27/9/202323:00BWCoya Therapeutics to Present at the LD Micro Investor..
22/9/202323:00BWCoya Therapeutics Licenses Exclusive Worldwide rights to..
07/9/202323:15BWCoya Therapeutics Successfully Engineers Regulatory T Cell..
31/8/202322:00BWCoya Therapeutics Announces Publication of Potential Novel..
25/8/202323:00BWCoya Therapeutics To Present Novel Proof of Concept Exosome..
22/8/202307:01EDGAR2Form 8-K - Current report
21/8/202321:00BWFormer CEO and Chairman of the Board of Bayer Pharma AG,..
08/8/202321:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

Delayed Upgrade Clock